Market closed
Nexalin Technology Inc./$NXL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Ticker
$NXL
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
6
Website
NXL Metrics
BasicAdvanced
$22M
-
-$0.83
4.39
-
Price and volume
Market cap
$22M
Beta
4.39
52-week high
$2.80
52-week low
$1.49
Average daily volume
120K
Financial strength
Current ratio
7.246
Quick ratio
6.389
Management effectiveness
Return on assets (TTM)
-123.41%
Return on equity (TTM)
-221.05%
Valuation
Price to revenue (TTM)
90.676
Price to book
6.01
Price to tangible book (TTM)
6.47
Price to free cash flow (TTM)
-3.718
Growth
Revenue change (TTM)
52.35%
Earnings per share change (TTM)
30.64%
3-year revenue growth (CAGR)
5.41%
3-year earnings per share growth (CAGR)
-16.70%
NXL News
AllArticlesVideos
Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders
GlobeNewsWire·3 days ago
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
GlobeNewsWire·2 weeks ago
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Nexalin Technology Inc. stock?
Nexalin Technology Inc. (NXL) has a market cap of $22M as of April 17, 2025.
What is the P/E ratio for Nexalin Technology Inc. stock?
The price to earnings (P/E) ratio for Nexalin Technology Inc. (NXL) stock is 0 as of April 17, 2025.
Does Nexalin Technology Inc. stock pay dividends?
No, Nexalin Technology Inc. (NXL) stock does not pay dividends to its shareholders as of April 17, 2025.
When is the next Nexalin Technology Inc. dividend payment date?
Nexalin Technology Inc. (NXL) stock does not pay dividends to its shareholders.
What is the beta indicator for Nexalin Technology Inc.?
Nexalin Technology Inc. (NXL) has a beta rating of 4.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.